Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: A potential implication in tumorigenesis

Digestive Diseases and Sciences

Volumn 43, Issue 1, 1998, Pages 26-32

  Duan, R D ^a   Cheng, Y ^b   Tauschel, H D ^b   Nilsson, A ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Alkaline sphingomyelinase; Bile; Bile salts; Colon cancer; Ursodeoxycholate

Indexed keywords

ALKALINE PHOSPHATASE; BILE SALT; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; SPHINGOMYELIN PHOSPHODIESTERASE; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; INTESTINE LOOP; INTESTINE MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; BILE ACIDS AND SALTS; CHOLIC ACIDS; COLONIC NEOPLASMS; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; INTESTINAL MUCOSA; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOMYELIN PHOSPHODIESTERASE; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

EID: 0031936162     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018807600683     Document Type: Article

References (39)

1. Narisawa T, Magadia NE, Weisburger JH, Wynder EL: Promoting effect of bile salts on colon cancinogenesis after intrarectal instillation of N-methyl-N-nitrosoguanidine in rats. J Natl Cancer Inst 53:1093-1097, 1974
2. Reddy BS, Narisawa T, Weisburger JH, Wynder EL: Promoting effect of sodium deoxycholate on colon adenocarcinomas in germ-free rats. J Natl Cancer Inst 56:441-442, 1976
3. Cohen BI, Raicht RF, Deschner EE, Takahashi M, Sarwal AN, Fazzini E: Effect of cholic acid feeding on N-methyl-N-nitrosourea induced colon tumors and cell kinetics in rats. J Natl Cancer Inst 64:573-578, 1980
4. Koga S, Kaibara N, Takeda R: Effect of bile acids on 1,2-dimethylhydrazine-induced colon cancer in rats. Cancer 50:543-547, 1982
5. Mower HF, Ray RM, Shoff R, Stemmermann GN, Nomura A, Glober GA, Kamiyama S, Shimada A, Yamakawa H: Fecal bile acids in two Japanese populations with different colon cancer risks. Can Res 39:328-331, 1979
6. Johansen C, Chow W-H, Jorgensen T, Mellemkjaer L, Engholm G, Olsen JH: Risk of colorectal cancer and other cancers in patients with gall stones. Gut 39:439-443, 1996
7. Weiss NS, Daling JR, Chow W-H: Cholecystectomy and the incidence of cancer of the large bowel. Cancer 49:1713-1715, 1982
8. Alley PG, Lee SP: The increased risk of proximal colonic cancer after cholecystectomy. Dis Colon Rectum 26:522-524, 1983
9. Broome U, Löfberg R, Verses B, Eriksson LS: Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential. Hepatology 22:1404-1408, 1995
10. Earnest DL, Holubec H, Wali RK, Jolley CS, Bissonette M, Bhattacharyya AK, Roy H, Khare S, Brasitus TA: Chemoprevention of azoxymethane-induced colonie carcinogenesis by supplemental dietary ursodeoxycholic acid. Can Res 54:5071-5074, 1994
11. Merrill AH, Schmelz EM, Wang E, Schroeder JJ, Dillehay DL, Riley RT: Role of dietary sphingolipids and inhibitors of sphingolipids metabolism in cancer and other diseases. J Nutr 125:16775-16825, 1995
12. Gelderblom WCA, Kriek NPJ, Marasas WFO, Thiel PG: Toxicity and carcinogenicity of the fusarium moniliforme metabolism, fumonisin B1, in rats. Carcinogenesis 12:1247-1251, 1991
13. Dudeja PK, Dahiya R, Brasitus TA: The role of sphingomyelin and sphingomyelinase in 1,2-dimethylhydrazine-induced lipid alterations of rat colonie plasma membrane. Biochim Biophys Acta 863:309-312, 1986
14. Dillehay DL, Webb SK, Schmelz EM, Merrill AH: Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124:615-620, 1994
15. Hertervig E, Nilsson Å, Nyberg L, Duan R-D: Alkaline sphingomyelinase activity is decreased in human colorectal cancer. Cancer 79:448-453, 1997
16. Duan R-D, Hertervig E, Hauge T, Nyberg L, Nilsson Å: Specific decrease in alkaline sphingomyelinase activity in human colorectal cancer and adenomas. Gastroenterology 110(suppl):A509, 1996
17. Nilsson Å: The presence of sphingomyelin-and ceramide-cleaving enzyme in the small intestinal tract. Biochim Biophys Acta 176:339-347, 1969
18. Duan R-D, Nyberg L, Nilsson Å: Alkaline sphingomyelinase activity in rat gastrointestinal tract: Distribution and characteristics. Biochim Biophys Acta 1259:1060-1065, 1995
19. Spence MW: Sphingomyelinase. Adv Lipid Res 26:3-23, 1993
20. Chatterjee S: Neutral sphingomyelinase. Adv Lipid Res 26:25-57, 1993
21. Duan R-D, Hertervig E, Nyberg L, Hauge T, Sternby B, Lillienau J, Farooqi A, Nilsson Å: Distribution of alkaline sphingomyelinase activity in human beings and animals, tissue and species differences. Dig Dis Sci 41:1801-1806, 1996
22. Nyberg L, Duan R-D, Axelson J, Nilsson Å: Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta 1300:42-48, 1996
23. Kolesnick RN: Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 30:1-38, 1991
24. Hannun YA, Obeid LM: Ceramide: an intracellular signal for apoptosis. TIBS 20:73-77, 1995
25. Shiozaki H, Yoshioka M, Miura S, Imaeda H, Morita A, Asakura H, Tsuchiya M, Ishii H: Conjugated bile salts regulate turnover of rat intestinal brush border membrane hydrolases. Dig Dis Sci 40:1193-1198, 1995
26. Accatino L, Pizarro M, Sous N, Koenig CS: Association of canalicular membrane enzymes with bile acid micelles and lipid aggregates in human and rat bile. Biochim Biophys Acta 1243:33-42, 1995
27. Nyberg L, Burling H: Methods for extracting sphingomyelin, SE-patent 9300454-7, Patent & Registreringsverket, Stockholm, 1993
28. Stoffel W: Chemical synthesis of choline-labeled lacithins and sphingomyelin. Methods Enzymol 36:533-541, 1975
29. Bowman BB, Rosenberg IH: Biotin absorption by distal rat intestine. J Nutr 117:2121-2126, 1987
30. Hofmann AF: Bile acids. In The Liver, Biology and Pathology. IM Arias, WB Jakoby, H Popper, D Schachter, DA Shafritz (eds). New York, Raven Press, 1988, pp 553-572
31. Lillienau J, Grombie DL, Munoz J, Longmire-Cook SJ, Hagey LR, Hofmann AF: Negative feedback regulation of the ileal bile acid transport system in rodents. Gastroenterology 104:38-46, 1993
32. Billington D, Evans CE, Godfrey PP, Coleman R: Effects of bile salts on the plasma membrane of isolated rat hepatocytes. Biochem J 188:321-327, 1980
33. Barnwell SG, Lowe PJ, Coleman R: Effect of taurochenodeoxycholate or tauroursodeoxycholate upon biliary output of phospholipids and plasma-membrane enzymes, and the extent of cell damage, in isolated perfused rat livers. Biochim J 216:107-111, 1983
34. Kitani K, Ohta M, Kanai S: Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 248:G407-G417, 1985
35. Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A: Ursodeoxycholate reduces hepatoxicity of bile salts in primary human hepatocytes. Hepatology 12:486-491, 1990
36. Chadwick VS, Gaginella TS, Carlson GL, Debongnie J-C, Phillips SF, Hofmann AF: Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rat colon. J Lab Clin Invest 94:661-674, 1979
37. Koga Y: Anti-cholestatic and cytoprotective properties of ursodeoxycholic acid. Studies in vivo and in vitro. Acta Hepatol Jpn 28:1597-1604, 1987
38. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Homilton SR, Jones RJ: Inhibition of apoptosis during development of colorectal cancer. Can Res 55:1811-1816, 1995
39. Rigas B, Tsioulias GJ, Allan C, Wali R, Brasitus TA: Ursodeoxycholic acid and piroxicam up-regulate MHC antigen expression in rat colonocytes during colon cancer development. Gastroenterology 106:A433, 1994